WE FIGHT MALARIA 24/7/365.
Last year, malaria killed more than 1,000 children EVERY DAY.
The world needs a highly effective vaccine to help eliminate malaria globally.
To aid this effort, we and our collaborators study animals and humans immunized
with Plasmodium sporozoites to decipher protective immune responses, identify
key proteins expressed by the parasite and create more effective vaccines.
We also develop ultrasensitive diagnostic tests to support malaria clinical trials & field studies.
With the Seattle Malaria Clinical Trials Center, we also perform Controlled Human
Malaria Infection studies to test new drugs and vaccines in human clinical trials.
The world needs a highly effective vaccine to help eliminate malaria globally.
To aid this effort, we and our collaborators study animals and humans immunized
with Plasmodium sporozoites to decipher protective immune responses, identify
key proteins expressed by the parasite and create more effective vaccines.
We also develop ultrasensitive diagnostic tests to support malaria clinical trials & field studies.
With the Seattle Malaria Clinical Trials Center, we also perform Controlled Human
Malaria Infection studies to test new drugs and vaccines in human clinical trials.
AND NOW WE FIGHT SARS-COV-2 AS WELL!
In March 2020, we initiated a T cell-focused vaccine project to fight the SARS-CoV-2 virus. In the first month of our project, we designed and produced several candidate vaccines and began testing these in mice early April 2020. We are thrilled to see vaccines rolling out from Pfizer, Moderna, Astra-Zeneca, and other manufacturers. Our SARS-CoV-2 vaccine project continues with a focus on T cells since T cells are known to persist for more than a decade and may offer long-term protection if an effective T cell-based vaccine could be developed. Link to the Spring 2020 video is here too!
, Ben
Thanks for exploring our work.
Quick links:
Our Research - Publications - Contact us - Fund our research
Twitter: @WeFightMalaria
Homepage image below: Our socially-distanced mosaic of 2020-2021 lab members.
Top left to right: Melanie, Sean, Felicia, Jamie, Bekah, Dianna, Ben
Bottom left to right: Caroline, Haley, Mariko, Anya, Ming, Kurtis, Mabel
Thanks for exploring our work.
Quick links:
Our Research - Publications - Contact us - Fund our research
Twitter: @WeFightMalaria
Homepage image below: Our socially-distanced mosaic of 2020-2021 lab members.
Top left to right: Melanie, Sean, Felicia, Jamie, Bekah, Dianna, Ben
Bottom left to right: Caroline, Haley, Mariko, Anya, Ming, Kurtis, Mabel
COMMITMENT TO DIVERSITY, EQUITY, AND INCLUSION: The Murphy Laboratory, the Department of Laboratory Medicine and Pathology, the University of Washington, and our affiliates and partners are committed to improving diversity, equity, and inclusion on our campus and beyond. Our intention is to create a research community that encourages participation and connection and that values each individual's unique contributions regardless of socioeconomic status, race, culture, ethnicity, language, nationality, sex, sexual orientation, gender identity and expression, spiritual practice, geography, mental and physical status or age.
DISCLAIMER: This is not an official University of Washington website. Views expressed on this site do not represent any official position of the University. Views expressed are those of Dr. Murphy and/or other contributors.
Last updated 12/30/2020 - LAB USE
Skyline photo by Oakie on Unsplash
DISCLAIMER: This is not an official University of Washington website. Views expressed on this site do not represent any official position of the University. Views expressed are those of Dr. Murphy and/or other contributors.
Last updated 12/30/2020 - LAB USE
Skyline photo by Oakie on Unsplash